PMC:7594251 / 2484-2627 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14710","span":{"begin":44,"end":45},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5958","span":{"begin":65,"end":72},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T70818","span":{"begin":118,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significa"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17","span":{"begin":24,"end":28},"obj":"Chemical"}],"attributes":[{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":" investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significa"}